Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.United States |
First Approval Date31 Oct 1986 |
100 Clinical Results associated with Draximage, Inc.
0 Patents (Medical) associated with Draximage, Inc.
100 Deals associated with Draximage, Inc.
100 Translational Medicine associated with Draximage, Inc.